Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PRAD | rs73807207 | chr5:154309518 | G/A | 0 | 492 | 30.3 | 32.4 | 4.87 | KM Plot |
| PRAD | rs73807213 | chr5:154345416 | T/C | 6.59E-7 | 487 | 30.33 | 33.47 | 20.47 | KM Plot |
| PRAD | rs73807216 | chr5:154348533 | T/C | 0 | 488 | 30.33 | 32.52 | 4.87 | KM Plot |
| PRAD | rs73809507 | chr5:154303169 | A/T | 0 | 493 | 30.33 | 32.4 | 4.87 | KM Plot |
| PRAD | rs7389839 | chr9:118220398 | T/C | 3.18E-6 | 494 | 20 | 31.27 | 31 | KM Plot |
| PRAD | rs73926967 | chr2:47160836 | G/A | 6.12E-6 | 494 | 30.8 | 32.4 | 36.77 | KM Plot |
| PRAD | rs73926970 | chr2:47161034 | G/C | 6.12E-6 | 494 | 30.8 | 32.4 | 36.77 | KM Plot |
| PRAD | rs73926978 | chr2:47161164 | T/C | 6.12E-6 | 494 | 30.8 | 32.4 | 36.77 | KM Plot |
| PRAD | rs73926980 | chr2:47165549 | T/A | 3.1E-6 | 492 | 30.8 | 32.4 | 36.77 | KM Plot |
| PRAD | rs73926982 | chr2:47165637 | C/T | 3.1E-6 | 492 | 30.8 | 32.4 | 36.77 | KM Plot |
| PRAD | rs73926983 | chr2:47165638 | A/G | 3.1E-6 | 492 | 30.8 | 32.4 | 36.77 | KM Plot |
| PRAD | rs7409047 | chr19:49980475 | A/T | 7.19E-7 | 478 | 30.3 | 33.3 | 24.25 | KM Plot |
| PRAD | rs7411324 | chr1:202690525 | G/A | 9.91E-6 | 493 | 30.93 | 29.5 | 27.92 | KM Plot |
| PRAD | rs742018 | chr22:45604885 | C/T | 5.01E-5 | 494 | 31.27 | 32.18 | 24.13 | KM Plot |
| PRAD | rs74228400 | chr1:93801186 | A/T | 3.59E-6 | 494 | 31.37 | 26.8 | 18.97 | KM Plot |